What this is
BlindSpot is a research prototype built at HACK1984, Northeastern University, in November 2026. This website describes it. By using the website or the software, you agree to these terms.
Not medical advice
- BlindSpot gives general information drawn from public FDA and NLM text. It is not medical advice, and it doesn't replace clinical judgement, a pharmacist or the full prescribing information.
- Answers are written by a small local language model and can be wrong, incomplete or out of date. Always check the cited source before acting on an answer.
- BlindSpot is not a medical device and has not been cleared or approved by the FDA or any other regulator.
Use synthetic data only
The prototype is for demonstration and research with synthetic patients. Don't use it to make clinical decisions, and don't enter real protected health information. Its security design and tests are described on How it works, together with its known limits; they have not been independently audited.
No warranty
The website and software are provided "as is", without warranties of any kind, express or implied, including fitness for a particular purpose. To the fullest extent the law allows, the authors aren't liable for any loss or harm arising from their use.
Sources and links
FDA drug labels and NLM MedlinePlus text are works of the US government. Research papers, surveys and news articles are cited and linked to their publishers, who own them. Links to other sites are provided for reference; we don't control those sites.
The code
The source code is on GitHub. Any license terms for it are those stated in the repository.
Changes and contact
We may update these terms; the date at the top of this page shows the latest version. Questions: open an issue on GitHub.